ABP 234 clinical trials

A Study to Compare ABP 234 and Keytruda® (Pembrolizumab) in Participants With Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer

This study compares a new medicine, ABP 234, with an existing treatment called Keytruda (pembrolizumab) for advanced lung cancer. Researchers want to see if ABP 234 works similarly to Keytruda. It's for people with a specific type of non-small cell lung cancer that has spread.